Pesticide Associated Lymphomas: Expression of Treatment Resistance Genes

Plain-language summary

This study examines the expression of treatment-resistance genes in relation to pesticide exposure in patients treated for diffuse large B-cell lymphoma. Eligible participants are adults diagnosed between 2010 and 2015 who received R-CHOP immunochemotherapy. It was conducted as an observational study without a formal phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

University Hospital, Montpellier

Start date

2/20/2018

Estimated completion

1/31/2019

Countries

France

Related genes

Locations

• Montpellier, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

Adults treated for diffuse large B-cell lymphoma:

* Diagnosed between 2010 and 2015
* Included in ProLyPhy search
* Having received R-CHOP immuno-chemotherapy
* Supported in health facilities in Languedoc-Rousillon

Exclusion criterion:

NA